Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial - Concepedia

Concepedia

Publication | Open Access

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

DOI Full Paper Access

53

Citations

15

References

2015

Year

Guillem Argilés, Mark Saunders, Fernando Rivera, Alberto Sobrero, Al B. Benson, Carmen Guillén‐Ponce, Stefano Cascinu, Eric Van Cutsem, Iain R. Macpherson, Dirk Strumberg,

European Journal of Cancer

Modified Folfox6Gastrointestinal OncologyMedicinePharmacologyColorectal CancerMetastatic Colorectal CancerFirst-line TreatmentPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1